Concepedia

Larry M. Tremaine

LM

Statistics

Publications

33

Citations

2.2K

H-Index

23

Active since

1982

Affiliations

Pfizer (United States)(Current)

University of Minnesota

Bristol-Myers Squibb (United States)

The Ohio State University

University of Manchester

Larry M. Tremaine is an author at Pfizer (United States) specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

1982–2025

33

Publications

33

The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions

R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 437 citations

, , +17

SERTRALINE IS METABOLIZED BY MULTIPLE CYTOCHROME P450 ENZYMES, MONOAMINE OXIDASES, AND GLUCURONYL TRANSFERASES IN HUMAN: AN IN VITRO STUDY

R. Scott Obach, Loretta M. Cox, Larry M. Tremaine · Drug Metabolism and Disposition · 2004 · 216 citations

, , +17

Pharmacokinetics of Sertraline and its N-Demethyl Metabolite in Elderly and Young Male and Female Volunteers

Robert A. Ronfeld, Larry M. Tremaine, Keith D. Wilner · Clinical Pharmacokinetics · 1997 · 149 citations

, , +10

Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs

Raman Sharma, Timothy J. Strelevitz, Hongying Gao et al. · Drug Metabolism and Disposition · 2011 · 114 citations

, , +17

A Novel Relay Method for Determining Low-Clearance Values

Li Di, Patrick Trapa, R. Scott Obach et al. · Drug Metabolism and Disposition · 2012 · 109 citations

, , +17

1–5 of 33